Hakan Tayfun, Toklu Hale Z, Biber Necat, Ozevren Huseyin, Solakoglu Seyhun, Demirturk Pelin, Aker Fugen V
Department of Neurosurgery, Haydarpasa Numune Teaching and Research Hospital, Istanbul 34668, Turkey.
Neurol Res. 2010 Jul;32(6):629-35. doi: 10.1179/016164109X12464612122731. Epub 2009 Aug 5.
The overproduction of reactive oxygen species and resultant damage to cellular proteins or lipids of cell membranes and DNA by free radicals are the underlying mechanisms of many neuropathologies. Cyclooxygenase-2 (COX-2) inhibitors have been suggested to be neuroprotective by reducing prostanoid and free radical synthesis, or by directing arachidonic acid metabolism through alternate pathways. This study investigated the putative neuroprotective effect of the COX-2 inhibitor, meloxicam, in a rat model of diffuse brain injury.
Sprague-Dawley rats were subjected to traumatic brain injury with a weight-drop device using 300 g(-1) m weight-height impact. The groups were: control, meloxicam (2 mg/kg, i.p.), trauma and trauma + meloxicam (2 mg/kg, i.p.). Forty-eight hours after the injury, neurological examination scores were measured, the animals were decapitated and brain tissues were taken. Brain edema and blood-brain barrier (BBB) permeability were evaluated by wet-dry weight method and Evans blue (EB) extravasation respectively. In brain tissues, malonedialdehyde, glutathione, myeloperoxidase and Na/K-ATPase levels were measured.
The neurological examination scores mildly increased in trauma groups 48 hours after the induction of trauma. Meloxicam treatment improved the altered neurological status. The trauma caused a significant increase in brain water content that was partially reversed by meloxicam. Meloxicam also reduced the EB extravasation indicating the preservation of the BBB integrity. Meloxicam treatment also significantly reduced the increase in malondialdehyde and myeloperoxidase levels and restored glutathione content of the brains that had been significantly increased after trauma.
Meloxicam exerts neuroprotective effect by preserving BBB permeability and by reducing brain edema (probably by its anti-inflammatory properties) in the diffuse brain injury model.
活性氧的过度产生以及自由基对细胞膜的细胞蛋白、脂质和DNA造成的损伤是许多神经病理学的潜在机制。环氧合酶-2(COX-2)抑制剂被认为可通过减少前列腺素和自由基合成,或通过替代途径引导花生四烯酸代谢而具有神经保护作用。本研究在大鼠弥漫性脑损伤模型中研究了COX-2抑制剂美洛昔康的假定神经保护作用。
使用300 g(-1)m体重-高度撞击的重物下落装置对Sprague-Dawley大鼠造成创伤性脑损伤。分组为:对照组、美洛昔康组(2 mg/kg,腹腔注射)、创伤组和创伤+美洛昔康组(2 mg/kg,腹腔注射)。损伤后48小时,测量神经学检查评分,将动物断头并取脑组织。分别通过干湿重法和伊文思蓝(EB)外渗评估脑水肿和血脑屏障(BBB)通透性。测量脑组织中丙二醛、谷胱甘肽、髓过氧化物酶和钠钾ATP酶水平。
创伤组在创伤诱导后48小时神经学检查评分略有增加。美洛昔康治疗改善了改变的神经状态。创伤导致脑含水量显著增加,美洛昔康部分逆转了这一情况。美洛昔康还减少了EB外渗,表明BBB完整性得到保留。美洛昔康治疗还显著降低了丙二醛和髓过氧化物酶水平的升高,并恢复了创伤后显著增加的脑组织谷胱甘肽含量。
在弥漫性脑损伤模型中,美洛昔康通过保留BBB通透性和减轻脑水肿(可能通过其抗炎特性)发挥神经保护作用。